The S47 p53 variant shows an impaired ability to transcriptionally induce a subset of p53 target genes, including two well-known genes involved in metabolism, GLS2 and SCO2, suggesting that the defect in metabolic regulation may contribute to the reduced ferroptosis and the tumor-prone phenotype observed in S47 mice [127]. The gene discussed is GLS2; the disease is neoplasm.